Telemedicine for Hyperkinetic Movement Disorders.


Journal

Tremor and other hyperkinetic movements (New York, N.Y.)
ISSN: 2160-8288
Titre abrégé: Tremor Other Hyperkinet Mov (N Y)
Pays: England
ID NLM: 101569493

Informations de publication

Date de publication:
2020
Historique:
received: 30 06 2019
accepted: 17 01 2020
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 16 11 2021
Statut: epublish

Résumé

Telemedicine is the use of electronic communication technology to facilitate healthcare between distant providers and patients. In addition to synchronous video conferencing, asynchronous video transfer has been used to support care for neurology patients. There is a growing literature on using telemedicine in movement disorders, with the most common focus on Parkinson's disease. There is accumulating evidence for videoconferencing to diagnose and treat patients with hyperkinetic movement disorders and to support providers in remote underserviced areas. Cognitive testing has been shown to be feasible remotely. Genetic counseling and other counseling-based therapeutic interventions have also successfully performed in hyperkinetic movement disorders. We use a problem-based approach to review the current evidence for the use of telemedicine in various hyperkinetic movement disorders. This Viewpoint attempts to identify possible telemedicine solutions as well as discussing unmet needs and future directions.

Identifiants

pubmed: 32195039
doi: 10.7916/tohm.v0.698
pii: tre-10-698
pmc: PMC7070700
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020 Srinivasan R et al.

Déclaration de conflit d'intérêts

Funding: None. Conflict of Interest: The authors report no conflicts of interest. Ethics Statement: Not applicable for this category of article.

Références

J Telemed Telecare. 2019 Jun 17;:1357633X19853140
pubmed: 31208263
Parkinsonism Relat Disord. 2013 Feb;19(2):218-21
pubmed: 23102808
JAMA Neurol. 2013 May;70(5):565-70
pubmed: 23479138
Mov Disord. 2002 May;17(3):513-7
pubmed: 12112199
Tremor Other Hyperkinet Mov (N Y). 2017 Oct 19;7:501
pubmed: 29123943
BMJ Open. 2019 Feb 15;9(2):e024685
pubmed: 30772854
Mov Disord. 2019 May;34(5):657-663
pubmed: 30901495
Mov Disord. 2014 Jun;29(7):871-83
pubmed: 24838316
Mov Disord. 2016 Sep;31(9):1258-62
pubmed: 27501323
IEEE Trans Neural Syst Rehabil Eng. 2014 Sep;22(5):982-91
pubmed: 24760943
J Parkinsons Dis. 2012;2(1):47-55
pubmed: 23939408
Neurol Int. 2018 Mar 30;10(1):7536
pubmed: 29844890
Pract Neurol. 2017 Oct;17(5):412-416
pubmed: 28676502
J Parkinsons Dis. 2019;9(2):401-404
pubmed: 31127732
J Huntingtons Dis. 2014;3(2):189-95
pubmed: 25062861
Tremor Other Hyperkinet Mov (N Y). 2019 Feb 18;9:625
pubmed: 30809420
Parkinsons Dis. 2019 Jan 6;2019:9403295
pubmed: 30723541
Health Informatics J. 2016 Jun;22(2):304-11
pubmed: 25391849
Artif Intell Med. 2016 Feb;67:47-56
pubmed: 26831150
Parkinsonism Relat Disord. 2014 May;20(5):541-4
pubmed: 24560600
Mov Disord. 2016 Sep;31(9):1337-8
pubmed: 27241524
Lancet Neurol. 2004 Oct;3(10):598-607
pubmed: 15380156
Mov Disord. 2004 Dec;19(12):1409-13
pubmed: 15390057
Mov Disord. 2013 Jul;28(8):1080-7
pubmed: 23520058
Clin Neuropharmacol. 2004 Mar-Apr;27(2):53-7
pubmed: 15252264
Lancet Neurol. 2017 Jul;16(7):541-551
pubmed: 28566190
J Huntingtons Dis. 2016 Jun 27;5(2):207-13
pubmed: 27372053
Telemed J E Health. 2019 Jul;25(7):541-550
pubmed: 30136898
Neurology. 2018 May 8;90(19):e1702-e1705
pubmed: 29626180
JAMA. 2014 Mar 5;311(9):948-54
pubmed: 24595779
PLoS One. 2017 Jun 6;12(6):e0178670
pubmed: 28586370
Cogn Behav Pract. 2017 Aug;24(3):374-381
pubmed: 28966546
Clin Psychol Rev. 2016 Dec;50:1-10
pubmed: 27668988
Mov Disord Clin Pract. 2018 Dec 13;6(1):65-69
pubmed: 30746418
Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5392-5396
pubmed: 28269477
Nat Rev Neurol. 2013 Jun;9(6):340-50
pubmed: 23649102
Stud Health Technol Inform. 2018;254:53-62
pubmed: 30306957
Mov Disord. 2003 Jan;18(1):70-80
pubmed: 12518302
Parkinsonism Relat Disord. 2016 Dec;33:44-50
pubmed: 27637282
Neuropsychiatr Dis Treat. 2010 Sep 07;6:401-8
pubmed: 20856604
J Telemed Telecare. 2016 Oct;22(7):391-6
pubmed: 26519377
Curr Neurol Neurosci Rep. 2018 Apr 13;18(5):26
pubmed: 29654523
Stud Health Technol Inform. 2018;254:77-85
pubmed: 30306960
J Telemed Telecare. 2005;11(7):368-71
pubmed: 16238839
Harefuah. 2018 Aug;157(8):503-506
pubmed: 30175565
Clin Genet. 2013 Jul;84(1):60-4
pubmed: 23039041

Auteurs

Ragini Srinivasan (R)

Centre for Movement Disorders, Toronto, Ontario, CA.

Hilla Ben-Pazi (H)

Pediatric Neurology Department, Assuta Ashdod, Ashdod, IL.

Marieke Dekker (M)

Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Moshi, TZ.

Esther Cubo (E)

Neurology Department, Hospital Universitario Burgos, Burgos, ES.

Bas Bloem (B)

Department of Neurology, Radbound Medical Center, Nijmegen, NL.

Emile Moukheiber (E)

Department of Neurology, John Hopkins University School of Medicine, Baltimore, MD, US.

Josefa Gonzalez-Santos (J)

Occupational Therapy Department, University of Burgos, Burgos, ES.

Mark Guttman (M)

Centre for Movement Disorders, Toronto, Ontario, CA.
Department of Internal Medicine, Division of Neurology, University of Toronto, Toronto, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH